机制(生物学)
药品
细胞因子释放综合征
医学
重症监护医学
药理学
药物开发
风险分析(工程)
2019年冠状病毒病(COVID-19)
疾病
病理
认识论
哲学
传染病(医学专业)
作者
Mindi Walker,Dorie Makropoulos,Ram Achuthanandam,Peter J. Bugelski
出处
期刊:PubMed
[National Institutes of Health]
日期:2010-01-01
卷期号:13 (1): 124-135
被引量:26
摘要
Infusion reactions and cytokine release syndrome (CRS) are an emerging issue in drug development and are of particular importance with the development of new therapeutic proteins. Increasing concerns regarding patient safety require a better understanding of the mechanism involved and the development of novel methods for preventing and predicting such reactions and CRS. This review discusses developments during the past few years in understanding the mechanisms that cause infusion reactions and CRS, advances in approaches to prevent CRS, the reason why preclinical animal models are unreliable predictors of CRS, and new developments in the design and analysis of in vitro screening systems for the prediction of CRS.
科研通智能强力驱动
Strongly Powered by AbleSci AI